insitro

insitro is a machine-learning-driven drug discovery and development company founded in 2018 by Daphne Koller and headquartered in South San Francisco, California. It combines large-scale in vitro cellular data generated in its own automated labs with human clinical and genetic data to build predictive models of biology, aiming to bring better drugs faster to the patients most likely to benefit. Its therapeutic focus spans metabolism, oncology, and neuroscience, and its interdisciplinary teams pair life scientists, data scientists, and engineers. insitro operates no public developer API; it maintains open-source research and infrastructure tooling (such as the redun workflow engine) on its GitHub organization. Backed by a16z, GV, and the SoftBank Vision Fund.

insitro is profiled on the APIs.io network. Tagged areas include Company, Drug Discovery, Machine Learning, Biotechnology, and Life Sciences.

14.5/100 minimal ▬ flat Agent 7/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyDrug DiscoveryMachine LearningBiotechnologyLife SciencesGenomicsPharmaceuticalsArtificial Intelligence

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.5/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 2.1 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 7/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 4 / 4
Consent & Bot Identity 3 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/insitro: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Insitro Domain Security

TLSv1.3 · DMARC

SECURITY

Insitro Vulnerability Disclosure

security.txt · contact published

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Build 2

SDKs, sample code, and the tooling you integrate with

Access & Security 4

Authentication, authorization, and security posture

Commercial 1

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: insitro
name: insitro
description: insitro is a machine-learning-driven drug discovery and development company founded in 2018 by Daphne Koller
  and headquartered in South San Francisco, California. It combines large-scale in vitro cellular data generated in its own
  automated labs with human clinical and genetic data to build predictive models of biology, aiming to bring better drugs
  faster to the patients most likely to benefit. Its therapeutic focus spans metabolism, oncology, and neuroscience, and its
  interdisciplinary teams pair life scientists, data scientists, and engineers. insitro operates no public developer API;
  it maintains open-source research and infrastructure tooling (such as the redun workflow engine) on its GitHub organization.
  Backed by a16z, GV, and the SoftBank Vision Fund.
url: https://raw.githubusercontent.com/api-evangelist/insitro/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.insitro.com/wp-content/uploads/2023/11/logo-insitro.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- gv
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Drug Discovery
- Machine Learning
- Biotechnology
- Life Sciences
- Genomics
- Pharmaceuticals
- Artificial Intelligence
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.insitro.com
- type: GitHubOrganization
  url: https://github.com/insitro
- type: PrivacyPolicy
  url: https://www.insitro.com/privacy-policy/
- type: Careers
  url: https://www.insitro.com/join-us/
- type: Packages
  url: packages/insitro-packages.yml
- type: WellKnown
  url: well-known/insitro-well-known.yml
- type: SecurityTxt
  url: well-known/insitro-security.txt
- type: DomainSecurity
  url: security/insitro-domain-security.yml
- type: VulnerabilityDisclosure
  url: security/insitro-vulnerability-disclosure.yml
- type: Security
  url: well-known/insitro-security.txt
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence